Quantcast

Latest Interferon beta-1a Stories

2005-09-16 09:49:18

By Julie Steenhuysen and Sitaraman Shankar CHICAGO/FRANKFURT (Reuters) - A drug from Genzyme Corp. and Schering helped reduce the risk of relapses in multiple sclerosis patients, but caused a serious side effect in three cases that led to a death, the companies said on Friday.

2004-11-27 12:00:07

WASHINGTON -- The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans. The drug -- a monoclonal antibody produced by Cambridge, Mass.- based Biogen Idec Inc.

2004-11-26 18:00:09

FRIDAY, Nov. 26 (HealthDayNews) -- The U.S. Food and Drug Administration has approved Tysabri (natalizumab) as a new treatment for multiple sclerosis. The incurable nervous system disease affects about 350,000 Americans.

2004-11-26 06:00:07

WASHINGTON -- The government approved a drug Tuesday that tries a new method of attacking multiple sclerosis, an incurable disease of the central nervous system that affects 350,000 Americans. The drug -- a monoclonal antibody produced by Cambridge, Mass.- based Biogen Idec Inc.


Word of the Day
shotta
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.